Fredag 1 November | 01:39:19 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

Tid*
2025-10-30 07:30 Kvartalsrapport 2025-Q3
2025-07-10 07:30 Kvartalsrapport 2025-Q2
2025-05-22 - Årsstämma
2025-05-03 07:30 Kvartalsrapport 2025-Q1
2025-02-13 07:30 Bokslutskommuniké 2024
2024-11-05 07:30 Kvartalsrapport 2024-Q3
2024-07-11 - Kvartalsrapport 2024-Q2
2024-06-28 - Årsstämma
2024-06-12 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2024-05-31 - Kvartalsrapport 2024-Q1
2024-02-27 - Bokslutskommuniké 2023
2023-11-02 - Kvartalsrapport 2023-Q3
2023-07-13 - Kvartalsrapport 2023-Q2
2023-07-03 - Extra Bolagsstämma 2023
2023-06-13 - Årsstämma
2023-05-24 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-05-25 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2022-05-24 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-05-26 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2021-05-25 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-07-16 - Kvartalsrapport 2020-Q2
2020-05-27 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2020-05-26 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-02-13 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-07-18 - Kvartalsrapport 2019-Q2
2019-05-23 - X-dag ordinarie utdelning QLINEA 0.00 SEK
2019-05-22 - Årsstämma
2019-05-03 - Kvartalsrapport 2019-Q1
2019-02-14 - Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Q-Linea är verksamt inom medicinteknik. Bolaget är specialiserat inom forskning och utveckling av instrument och förbrukningsartiklar. Produkterna används huvudsakligen vid behandling av infektionssjukdomar och blodförgiftning, och innefattar diagnostik- och analysverktyg, samt övrig grundläggande provhantering. Tekniken baseras på den så kallade ID- samt AST tekniken. Bolaget grundades 2008 och har huvudkontoret i Uppsala.
2023-07-03 15:25:00

Today on 3 July 2023, Q-linea AB (publ) (the “Company”) held an extraordinary general meeting in Uppsala, whereby the resolutions below were adopted.

The general meeting was held at Hubben on Dag Hammarskjölds väg 38 in Uppsala. For more detailed information on the content of the resolutions, please see the complete notice of the extra general meeting that is available on the Company’s website, www.qlinea.com. Minutes from the extra general meeting will be provided on the said website within two weeks from the day of the meeting.

Adoption on new articles of association
The general meeting resolved to adopt new articles of association in accordance with the board’s proposal, entailing an amendment of the limits of the share capital and the number of shares.
·       The limits of the share capital in §4 is amended, entailing the following wording:
The share capital shall be at least 5,750,000 and maximum 23,000,000 SEK.
·       The limits of the numbers of shares in §5 is amended, entailing the following wording:
The number of shares shall be at least 115,000,000 and maximum 460,000,000.

The general meeting’s subsequent approval of the board's resolution on 1 June 2023 regarding the issue of new common shares with preferential rights for existing shareholders
The general meeting resolved to approve the board’s resolution on a rights issue which was resolved on by the board on 1 June 2023.
The preferential share issue includes a share issue of of not more than 87,628,425 new common shares which entails an increase of the Company’s share capital with not more than SEK 4,381,421.25. The right to subscribe for new common shares shall belong to those persons who on the record date for the new issue of shares are recorded as shareholders of the Company, where one (1) existing share shall entitle to three (3) new common shares (i.e. a subscription ration of 3:1). Should all new shares not be subscribed based on subscription rights, the board shall resolve on the allocation of new shares without subscription rights according to certain principles described in the notice to the general meeting, where allocation is ultimately made to those who have entered into guarantee commitments.
The new shares are issued at a subscription price of SEK 3 per share. The record date for participation in the new issue shall be 5 July 2023.
All resolutions by the general meeting were adopted by the required majority.
***